Dongwha Pharm.Co.,Ltd (000020.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩5,200 (+1.56%) as of
Key statistics
- Market cap
- 144.13B
- Dividend yield
- 1.27%
- 52-week range
- 4,450.00 – 7,560.00
- Beta
- 0.40
- Revenue (TTM)
- 513.24B
- Profit margin
- 3.52%
- Volume
- 98.60k
About Dongwha Pharm.Co.,Ltd
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
- Employees
- 795
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.